Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SINHCAF pseudogene 1 (SINHCAFP1, also known as HsT2323) is a pseudogene related to the functional gene SINHCAF (FAM60A), which encodes a protein component of the SIN3A–histone deacetylase (HDAC) complex[1]. Pseudogenes are typically non-functional copies or fragments of genes and do not encode active proteins. There is no evidence in the scientific literature that SINHCAFP1 itself encodes a functional molecule, serves a biological function, or is relevant as a therapeutic target. The parent gene, SINHCAF, is involved in epigenetic regulation and development, but the pseudogene does not participate in these activities. There are no known associated diseases, drug interactions, or biomarker roles for the pseudogene. As such, it is not considered a valid therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SINHCAF pseudogene 1 (SINHCAFP1).